MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,319,000 | +15.4% | 104,800 | +10.9% | 3.15% | -10.8% |
| Q2 2022 | $6,344,000 | +47.0% | 94,500 | +80.0% | 3.53% | +75.2% |
| Q1 2022 | $4,317,000 | +47.1% | 52,500 | +162.5% | 2.02% | +63.6% |
| Q4 2021 | $2,934,000 | +90.3% | 20,000 | +122.2% | 1.23% | +121.8% |
| Q1 2021 | $1,542,000 | +16.5% | 9,000 | -47.1% | 0.56% | -41.8% |
| Q3 2019 | $1,324,000 | -79.4% | 17,000 | -72.8% | 0.96% | -58.2% |
| Q2 2019 | $6,438,000 | +114.2% | 62,500 | +52.4% | 2.29% | +60.2% |
| Q1 2019 | $3,005,000 | -2.1% | 41,000 | -59.0% | 1.43% | +185.2% |
| Q1 2018 | $3,070,000 | +8.5% | 100,000 | -35.5% | 0.50% | -6.2% |
| Q4 2017 | $2,829,000 | +242.5% | 155,000 | +24.0% | 0.53% | +72.3% |
| Q3 2016 | $826,000 | +20.9% | 125,000 | 0.0% | 0.31% | -5.5% |
| Q2 2016 | $683,000 | -69.1% | 125,000 | +21.0% | 0.33% | -73.5% |
| Q1 2016 | $2,210,000 | -20.9% | 103,283 | +16.8% | 1.24% | -7.6% |
| Q4 2015 | $2,795,000 | – | 88,439 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |